Search by Drug Name or NDC
NDC 16714-0397-03 Cefprozil 250 mg/5mL Details
Cefprozil 250 mg/5mL
Cefprozil is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar Rx LLC. The primary component is CEFPROZIL.
MedlinePlus Drug Summary
Cefprozil is used to treat certain infections caused by bacteria, such as bronchitis (infection of the airway tubes leading to the lungs); and infections of the skin, ears, sinuses, throat, and tonsils ,. Cefprozil is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria. Antibiotics such as cefprozil will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 16714-0397-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cefprozil
Product Information
| NDC | 16714-0397 |
|---|---|
| Product ID | 16714-397_f8549985-02c2-4301-a433-fb846a06b078 |
| Associated GPIs | 02200062001920 |
| GCN Sequence Number | 016583 |
| GCN Sequence Number Description | cefprozil SUSP RECON 250 MG/5ML ORAL |
| HIC3 | W1X |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 2ND GENERATION |
| GCN | 29292 |
| HICL Sequence Number | 006316 |
| HICL Sequence Number Description | CEFPROZIL |
| Brand/Generic | Generic |
| Proprietary Name | Cefprozil |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cefprozil |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CEFPROZIL |
| Labeler Name | NorthStar Rx LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065381 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16714-0397-03 (16714039703)
| NDC Package Code | 16714-397-03 |
|---|---|
| Billing NDC | 16714039703 |
| Package | 100 mL in 1 BOTTLE (16714-397-03) |
| Marketing Start Date | 2007-01-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.22191 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | CEFPROZIL 250 MG/5 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis